·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊÆ÷ÀÎÆ®¸ôTVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ SK, 1Á¶1163¾ï SK¹ÙÀÌ¿ÀÆÊ ÁÖ½Ä Ã³ºÐ..."ÅõÀÚÀÚ±Ý È®º¸" ±â»çÀÔ·Â : 21.02.24 09:13:18 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] SK´Â SK¹ÙÀÌ¿ÀÆÊÀÇ ÁÖ½Ä 860¸¸ÁÖ¸¦ ½Ã°£¿Ü ´ë·®¸Å¸Å(ºí·Ïµô) ¹æ½ÄÀ¸·Î óºÐÇß´Ù°í 24ÀÏ °ø½ÃÇß´Ù. Àüü SK¹ÙÀÌ¿ÀÆÊÀÇ ÁÖ½Ä Áß 11.0%¿¡ ÇØ´çÇÏ´Â ±Ô¸ð´Ù. óºÐ ±Ý¾×Àº 1Á¶1163¾ï¿øÀÌ´Ù. 1ÁÖ´ç óºÐ ´Ü°¡´Â 12¸¸9800¿øÀ¸·Î Áö³ 23ÀÏ Á¾°¡ 14¸¸7500¿øº¸´Ù 13.6% ÇÒÀÎµÈ ±Ý¾×ÀÌ´Ù. SK´Â SK¹ÙÀÌ¿ÀÆÊÀÇ ÃÖ´ëÁÖÁÖ´Ù. À̹ø ºí·ÏµôÀ» ÅëÇØ º¸À¯ ÁÖ½ÄÀÇ 14.6%¸¦ óºÐÇß´Ù. SK ÃøÀº ¡°½Å¼ºÀ嵿·Â È®º¸¸¦ À§ÇÑ ÅõÀÚÀÚ±Ý È®º¸¡±¶ó°í óºÐ¸ñÀûÀ» ¼³¸íÇß´Ù. SKÀÇ SK¹ÙÀÌ¿ÀÆÊ ÁöºÐÀ²Àº 75.0%¿¡¼ 64.0%·Î ³·¾ÆÁ³´Ù. õ½ÂÇö ±âÀÚ(1000@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [SO & COMPANY] Medical Writer ¹Ù·Î°¡±â [CSL Behring] Marketing Product Manager ¹Ù·Î°¡±â Medical ¹× Clinical °¢ ºÎ¹® ä¿ë ¹Ù·Î°¡±â ¼¿Æ®¸®¿Â 2024³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â 2024³â Á¦3Â÷(¹ÌÀÀ½ÃºÐ¾ß)ä¿ë ¿¬Àå ¹× Àç°ø°í ¹Ù·Î°¡±â MSL (Medical Science Liason)_Á¤±ÔÁ÷ ¸ðÁý ¹Ù·Î°¡±â [»ï¿ø¾àÇ° ¿ï»êÁöÁ¡] °ü¸®¾à»ç´Ô ¸ðÁý°ø°í ¹Ù·Î°¡±â 2024³â ÇÑ¹Ì±×·ì »ó¹Ý±â Çѹ̱׷ì ÀÎÀç¸ðÁý [Á¤±â°øä] ¹Ù·Î°¡±â Medical Communication & Strategy ¹Ù·Î°¡±â Ç°Áú°ü¸®¾à»ç / Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â [CSL Behring] Medical Representative ¹Ù·Î°¡±â (´ëÀü/Ãæû) ¿µ¾÷ºÎ °æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â ¼Ûµµ/¿À¼Û/ºÎ»ê Á¦Á¶/Ç°Áú°ü¸® ¾à»ç ¸ðÁý ¹Ù·Î°¡±â JW±×·ì 24³â 2Â÷ ¼ö½Ãä¿ë ¹Ù·Î°¡±â ÃæºÏ ÃæÁֽà µµ¸Å °ü¸® ¾à»ç ¸ðÁý ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : SK, 1Á¶1163¾ï SK¹ÙÀÌ¿ÀÆÊ ÁÖ½Ä Ã³ºÐ...ÅõÀÚÀÚ±Ý È®º¸ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ SK, 1Á¶1163¾ï SK¹ÙÀÌ¿ÀÆÊ ÁÖ½Ä Ã³ºÐ..."ÅõÀÚÀÚ±Ý È®º¸" ±â»çÀÔ·Â : 21.02.24 09:13:18 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] SK´Â SK¹ÙÀÌ¿ÀÆÊÀÇ ÁÖ½Ä 860¸¸ÁÖ¸¦ ½Ã°£¿Ü ´ë·®¸Å¸Å(ºí·Ïµô) ¹æ½ÄÀ¸·Î óºÐÇß´Ù°í 24ÀÏ °ø½ÃÇß´Ù. Àüü SK¹ÙÀÌ¿ÀÆÊÀÇ ÁÖ½Ä Áß 11.0%¿¡ ÇØ´çÇÏ´Â ±Ô¸ð´Ù. óºÐ ±Ý¾×Àº 1Á¶1163¾ï¿øÀÌ´Ù. 1ÁÖ´ç óºÐ ´Ü°¡´Â 12¸¸9800¿øÀ¸·Î Áö³ 23ÀÏ Á¾°¡ 14¸¸7500¿øº¸´Ù 13.6% ÇÒÀÎµÈ ±Ý¾×ÀÌ´Ù. SK´Â SK¹ÙÀÌ¿ÀÆÊÀÇ ÃÖ´ëÁÖÁÖ´Ù. À̹ø ºí·ÏµôÀ» ÅëÇØ º¸À¯ ÁÖ½ÄÀÇ 14.6%¸¦ óºÐÇß´Ù. SK ÃøÀº ¡°½Å¼ºÀ嵿·Â È®º¸¸¦ À§ÇÑ ÅõÀÚÀÚ±Ý È®º¸¡±¶ó°í óºÐ¸ñÀûÀ» ¼³¸íÇß´Ù. SKÀÇ SK¹ÙÀÌ¿ÀÆÊ ÁöºÐÀ²Àº 75.0%¿¡¼ 64.0%·Î ³·¾ÆÁ³´Ù. õ½ÂÇö ±âÀÚ(1000@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [SO & COMPANY] Medical Writer ¹Ù·Î°¡±â [CSL Behring] Marketing Product Manager ¹Ù·Î°¡±â Medical ¹× Clinical °¢ ºÎ¹® ä¿ë ¹Ù·Î°¡±â ¼¿Æ®¸®¿Â 2024³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â 2024³â Á¦3Â÷(¹ÌÀÀ½ÃºÐ¾ß)ä¿ë ¿¬Àå ¹× Àç°ø°í ¹Ù·Î°¡±â MSL (Medical Science Liason)_Á¤±ÔÁ÷ ¸ðÁý ¹Ù·Î°¡±â [»ï¿ø¾àÇ° ¿ï»êÁöÁ¡] °ü¸®¾à»ç´Ô ¸ðÁý°ø°í ¹Ù·Î°¡±â 2024³â ÇÑ¹Ì±×·ì »ó¹Ý±â Çѹ̱׷ì ÀÎÀç¸ðÁý [Á¤±â°øä] ¹Ù·Î°¡±â Medical Communication & Strategy ¹Ù·Î°¡±â Ç°Áú°ü¸®¾à»ç / Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â [CSL Behring] Medical Representative ¹Ù·Î°¡±â (´ëÀü/Ãæû) ¿µ¾÷ºÎ °æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â ¼Ûµµ/¿À¼Û/ºÎ»ê Á¦Á¶/Ç°Áú°ü¸® ¾à»ç ¸ðÁý ¹Ù·Î°¡±â JW±×·ì 24³â 2Â÷ ¼ö½Ãä¿ë ¹Ù·Î°¡±â ÃæºÏ ÃæÁֽà µµ¸Å °ü¸® ¾à»ç ¸ðÁý ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : SK, 1Á¶1163¾ï SK¹ÙÀÌ¿ÀÆÊ ÁÖ½Ä Ã³ºÐ...ÅõÀÚÀÚ±Ý È®º¸ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ SK, 1Á¶1163¾ï SK¹ÙÀÌ¿ÀÆÊ ÁÖ½Ä Ã³ºÐ..."ÅõÀÚÀÚ±Ý È®º¸" ±â»çÀÔ·Â : 21.02.24 09:13:18 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] SK´Â SK¹ÙÀÌ¿ÀÆÊÀÇ ÁÖ½Ä 860¸¸ÁÖ¸¦ ½Ã°£¿Ü ´ë·®¸Å¸Å(ºí·Ïµô) ¹æ½ÄÀ¸·Î óºÐÇß´Ù°í 24ÀÏ °ø½ÃÇß´Ù. Àüü SK¹ÙÀÌ¿ÀÆÊÀÇ ÁÖ½Ä Áß 11.0%¿¡ ÇØ´çÇÏ´Â ±Ô¸ð´Ù. óºÐ ±Ý¾×Àº 1Á¶1163¾ï¿øÀÌ´Ù. 1ÁÖ´ç óºÐ ´Ü°¡´Â 12¸¸9800¿øÀ¸·Î Áö³ 23ÀÏ Á¾°¡ 14¸¸7500¿øº¸´Ù 13.6% ÇÒÀÎµÈ ±Ý¾×ÀÌ´Ù. SK´Â SK¹ÙÀÌ¿ÀÆÊÀÇ ÃÖ´ëÁÖÁÖ´Ù. À̹ø ºí·ÏµôÀ» ÅëÇØ º¸À¯ ÁÖ½ÄÀÇ 14.6%¸¦ óºÐÇß´Ù. SK ÃøÀº ¡°½Å¼ºÀ嵿·Â È®º¸¸¦ À§ÇÑ ÅõÀÚÀÚ±Ý È®º¸¡±¶ó°í óºÐ¸ñÀûÀ» ¼³¸íÇß´Ù. SKÀÇ SK¹ÙÀÌ¿ÀÆÊ ÁöºÐÀ²Àº 75.0%¿¡¼ 64.0%·Î ³·¾ÆÁ³´Ù. õ½ÂÇö ±âÀÚ(1000@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : SK, 1Á¶1163¾ï SK¹ÙÀÌ¿ÀÆÊ ÁÖ½Ä Ã³ºÐ...ÅõÀÚÀÚ±Ý È®º¸ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö